CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,348,362 | -31.1% | 95,800 | -14.8% | 0.00% | -33.3% |
| Q2 2023 | $6,310,136 | +58.4% | 112,400 | +27.6% | 0.01% | +20.0% |
| Q1 2023 | $3,984,763 | +51.5% | 88,100 | +36.2% | 0.01% | +25.0% |
| Q4 2022 | $2,630,055 | -54.7% | 64,700 | -27.1% | 0.00% | -42.9% |
| Q3 2022 | $5,803,000 | -17.3% | 88,800 | -23.1% | 0.01% | -30.0% |
| Q2 2022 | $7,013,000 | +22.2% | 115,400 | +26.3% | 0.01% | +66.7% |
| Q1 2022 | $5,737,000 | -31.4% | 91,400 | -17.2% | 0.01% | -14.3% |
| Q4 2021 | $8,366,000 | -41.8% | 110,400 | +24.3% | 0.01% | -61.1% |
| Q2 2021 | $14,376,000 | +48.4% | 88,800 | +11.7% | 0.02% | +28.6% |
| Q1 2021 | $9,687,000 | – | 79,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 225 | $1,060,000 | 0.10% |
| GROUP ONE TRADING, L.P. | 9,500 | $447,000 | 0.00% |
| SIMPLEX TRADING, LLC | 278 | $1,309,000 | 0.00% |
| JPMORGAN CHASE & CO | 31,900 | $1,447,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |